2017 Wisconsin Dermatological Society Fall Meeting
This educational activity is designed to enhance the knowledge of the academic and community dermatologists in Wisconsin. The 2017 WDS Fall Meeting will include four expert lectures on topics including current changes in the healthcare environment, juvenile pityriasis rubra pilaris genetics, and therapeutic options for melanoma and psoriasis.
In addition, virtual patient case presentations will be given highlighting rare and common conditions, as well as treatments. These patient cases have been selected to demonstrate key points in patient diagnosis and management and will emphasize application of evidence-based medicine and up-to-date references.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Target Audience
Dermatologists
Dermatopathologists
Dermatologic surgeons
Nurse Practitioners
Physicians Assisants
Dermatology Residents
Learning Objectives
At the conclusion of this activity, learners will be able to:
- Assess current changes in the health care environment and how they will affect dermatologists
- Explain juvenile pityriasis rubra pilaris genetics and future therapy options
- Describe new therapeutic options for melanoma and psoriasis
Yvonne Chiu, MD; Barbara Wilson, MD; Patricia Witman, MD; Kara Walton, MD; Michael Lee, MD; Brittany Lister, MD; Krisztian Nemeth, MD, PhD; Lauren Seline, MD; Laura Tisch, MD; Olushola Akinshemoyin Vaughn, MD; Nicole Bender, MD; Liza Gill, MD; April Zhang, MD; Shahab Babakoohi, MD; Daren Diiorio, MD; Travis Kuemmet, MD; Jacquelyn Majerowski, MD; India Hill, MD; and Christina Biggs, PA-C
All persons in control of content have NO relevant financial relationships to disclose with the exception of:
Alexa Kimball, MD Abbvie, Dermira, Lilly ICOS, Merck & Co, Novartis, Procter & Gamble Company, Sanofi/Regeneron, Janssen Pharmaceuticals,
Kenneth Gordon, MD Abbvie, Amgen, Celgene, Janssen, Eli Lilly, Dermira, Novartis, Boehringher Ingelheim, Valeant, Sun,
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Available Credit
- 4.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.50 Hours of ParticipationHours of Participation credit.